C
B. Kaboudin et al.
Letter
Synlett
O
O
O
P
O
O
OH
P
R
P
R
R
P
R
R
R
R
P
R
B
A
R
H
R
H
OH
OH
O
OH
O
OH OH
O
OH
OH OH
O
OH
Ph3P
rac-2
cis-3
trans-4
O
O
O
O
P
O
R
P
R
R
P
R
A
R
P
R
B
R
R
R
P
R
OH
OH
O
OH OH
OH
OH
O
OH
O
OH OH
O
X
Ph3P
OH
meso-2
cis-4
PriO2C
N-CO2Pri
PriO2C
NH-CO2Pri
N
N
PPh3
PPh3
A
B
Scheme 4
triphenylphosphine oxide with inversion of the configura-
tion. In the case of cis-4 derived from meso-2, the phosphi-
nate moiety rather than the alcoholic moiety preferably cy-
clizes to give a cyclic three-membered intermediate for ste-
ric reasons and the intermediate participates further to
form cis-3.
phonic and Aminophosphinic Acids; John Wiley & Sons: Chiches-
ter, 2000. (d) Gittens, S. A.; Bansal, G.; Zernicke, R. F.; Uludag, H.
Adv. Drug Deliv. Rev. 2005, 57, 1011. (e) Kavanagh, K. L.; Guo, K.;
Dunford, J. E.; Wu, X.; Knapp, S.; Ebetino, F. H.; Rogers, M. J.;
Russel, R. G. G.; Opermann, U. Proc. Natl. Acad. Sci. U.S.A. 2006,
103, 7829. (f) Latajka, R.; Krężel Mucha, A.; Jewgiński, M.;
Kafarski, P. J. Mol. Struct. 2008, 877, 64. (g) Cates, L. A.; Li, V.-S.
Pharm. Res. 1985, 2, 135. (h) Luckman, S. P.; Coxon, F. P.;
Ebetino, F. H.; Russell, G. G.; Rogers, M. J. J. Bone Miner. Res.
1998, 13, 1668. (i) Katoh, M.; Hiratake, J.; Kato, H.; Oda, J. Bioorg.
Med. Chem. Lett. 1996, 6, 1437. (j) Stowasser, B.; Budt, K.-H.;
Jian-Qi, L.; Peyman, A.; Ruppert, D. Tetrahedron Lett. 1992, 33,
6625.
In summary, we have developed a simple and practical
approach for the synthesis of a new class of organophos-
phorus compounds. Investigations showed that the conver-
sion proceeds through an intramolecular Mitsunobu cycli-
sation of bishydroxyphosphinic acids with a mixture of
triphenylphosphine and diisopropylazodicarboxylate in tol-
uene–CH2Cl2 at room temperature. The treatment of two
diastereomers of bishydroxymethylphosphinic acid (dl pair
and meso) with a mixture of triphenylphosphine and diiso-
propylazodicarboxylate gives only one stereoisomer of the
cyclic oxaphosphetane. The structure of the novel four-
membered cyclic oxaphosphetanes was determined by
HRMS and NMR analysis that confirmed the structure of
the cyclic phosphinic acid. Some of the major advantages of
this protocol are the simplicity of the procedure and work-
up and good yields.7
(2) (a) Chebib, M.; Johnston, G. A. R. J. Med. Chem. 2000, 43, 1427.
(b) Bormann, J. Trends Pharmacol. Sci. 2000, 21, 16.
(3) Gavande, N.; Yamamoto, I.; Salam, N. K.; Ai, T.-H.; Burden, P. M.;
Johnston, G. A. R.; Hanrahan, J. R.; Chebib, M. ACS Med. Chem.
Lett. 2011, 2, 11.
(4) (a) Kaboudin, B.; Faghihi, M. R.; Kazemi, F.; Yokomatsu, T. Chi-
rality 2015, 27, 71. (b) Kaboudin, B.; Moradi, K.; Barati, A.;
Abdollahi, H. J. Iran. Chem. Soc. 2013, 10, 763. (c) Kaboudin, B.;
Moradi, K.; Faghihi, M. R.; Mohammadi, F. J. Lumin. 2013, 139,
104. (d) Kaboudin, B.; Haghighat, H.; Alaei, S.; Yokomatsu, T.
Synlett 2012, 23, 1965. (e) Kaboudin, B.; Alaie, S.; Yokomatsu, T.
Tetrahedron: Asymmetry 2011, 22, 1813. (f) Kaboudin, B.;
Saadati, F.; Golshan, A.; Abdollahi, H.; Yokomatsu, T. J. Chem.
Eng. Data 2011, 56, 3651. (g) Kaboudin, B.; Saadati, F.;
Yokomatsu, T. Synlett 2010, 1837. (h) Kaboudin, B.; Saadati, F.
Tetrahedron Lett. 2009, 50, 1450.
Acknowledgment
The authors gratefully acknowledge support by the Institute for Ad-
vanced Studies in Basic Sciences (IASBS) Research Council.
(5) (a) Kaboudin, B.; Haghighat, H. Tetrahedron Lett. 2005, 46, 7955.
(b) Kaboudin, B.; Haghighat, H.; Yokomatsu, T. J. Org. Chem.
2006, 71, 6604. (c) Kaboudin, B.; Haghighat, H.; Yokomatsu, T.
Tetrahedron: Asymmetry 2008, 19, 862.
Supporting Information
(6) Kaboudin, B.; Haghighat, H.; Yokomatsu, T. Synthesis 2011,
3185.
(7) General Procedure for the Preparation of Cyclic Oxaphos-
phetanes 3
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
The bishydroxyalkylphosphinic acid 2 (2 mmol), obtained
according to the method of our previously published article,5
was added to a stirred mixture of triphenylphosphine (0.805 g,
3.07 mmol) and DIAD (0.6 mL, 3.07 mmol) in a mixture of dry
toluene–CH2Cl2 (5:1, 18 mL) at 0 °C under argon, and the solu-
tion was stirred for 30 min at 0 °C. Stirring was continued for 6
h at r.t. and then MeOH (0.2 mL) was added to the reaction mix-
References and Notes
(1) (a) Queff'elec, C.; Montchamp, J.-L. Org. Biomol. Chem. 2010, 8,
267. (b) Ye, Y.; Liu, M.; Kao, J. L.-F.; Marshall, G. R. Biopolymer
2008, 89, 72. (c) Kukhar, V. P.; Hudson, H. R. In Aminophos-
© Georg Thieme Verlag Stuttgart · New York — Synlett 2016, 27, A–D